{
    "Trade/Device Name(s)": [
        "ACE Cholesterol Reagent",
        "ACE HDL-C Reagent",
        "ACE LDL-C Reagent",
        "ACE Triglycerides Reagent"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K122757",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113262"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CHH",
        "LBS",
        "MRR",
        "CDT"
    ],
    "Summary Letter Date": "September 6, 2012",
    "Summary Letter Received Date": "September 7, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1175",
        "21 CFR 862.1475",
        "21 CFR 862.1705"
    ],
    "Regulation Name(s)": [
        "Cholesterol (Total) Test System",
        "LDL & VLDL Precipitation, Cholesterol Via Esterase-Oxidase, HDL",
        "System, Test, Low Density, Lipoprotein",
        "Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholesterol",
        "High density lipoprotein cholesterol (HDL-C)",
        "Low density lipoprotein cholesterol (LDL-C)",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACE Axcel Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic Esterase-Oxidase (Cholesterol)",
        "Detergent solubilization enzymatic method (HDL-C, LDL-C)",
        "Coupled enzymatic reaction (Triglycerides)"
    ],
    "Methodologies": [
        "Enzymatic colorimetric assay"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Alfa Wassermann ACE Cholesterol, HDL-C, LDL-C, and Triglycerides Reagents for quantitative measurement of lipid analytes using enzymatic methods on the ACE Axcel Clinical Chemistry System",
    "Indications for Use Summary": "Intended for quantitative determination of cholesterol, HDL-C, LDL-C, and triglyceride concentrations using the ACE Axcel Clinical Chemistry System in clinical and physician office laboratories; used in diagnosis and treatment of lipid and lipoprotein metabolism disorders, diabetes mellitus, atherosclerosis, liver and renal diseases, and endocrine disorders; for in vitro diagnostic use only",
    "fda_folder": "Clinical Chemistry"
}